Next Post

Akebia Therapeutics Reports First Quarter 2022 Financial Results and Business Update | News

[ad_1] Net Auryxia® (ferric citrate) product revenue of $41.4M, a 36% increase over Q1 2021 2022 Net Auryxia product revenue guidance of $165 – $170M Outlines refined strategic focus to deliver shareholder value Akebia to host conference call on Monday, May 9 at 4:30 p.m. ET CAMBRIDGE, Mass., May 9, […]